“…A wide range of activities can be explained by a large number of Ha-binding receptors such as cell surface glycoprotein CD44, the receptor for hyaluronic acid-mediated motility (RHAMM), and several other receptors possessing Ha-binding motifs, for example: transmembrane protein layilin, hyaluronic acid receptor for endocytosis (HARE), lymphatic vessel endocytic receptor (LYVE-1), and also intracellular HA-binding proteins including CDC37, RHAMM/IHABP, P-32, and IHABP4 (Underhill, 1992;Forsberg et al, 1994;Pohl et al, 2000;Pure and Cuff, 2001;Toole, 2001;Weigel et al, 2002;Hascall et al, 2004;Hajjaji et al, 2005;Nawrat et al, 2005;Hill et al, 2006;Iacob and Knudson, 2006). It has been shown that the HA level is elevated in various cancer cells (Lin and Stern, 2001) and it is believed to form a less dense matrix, thus enhancing the cell's motililty as well as invasive ability into other tissues (Hill et al, 2006).…”